Home › Funds › Lion Point Capital, LP › RCKT

Lion Point Capital, LP position in RCKT

ROCKET PHARMACEUTICALS INC · Health Care

Lion Point Capital, LP reported holding 86,000 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$294K, representing 1.41% of its reported portfolio and ranking #25 among its reported holdings. Lion Point Capital, LP has disclosed RCKT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)86.00K sh
Reported value held$294.12K
Portfolio Weight1.41%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's RCKT position evolved

Lion Point Capital, LP first disclosed a stake in RCKT in Q3 2025 at 86,000 shares (US$280K). The position peaked in Q1 2026 at 86,000 shares, worth US$308K. Across 4 filings, Lion Point Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 86,000 shares valued at US$294K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 86.00K $280.36K New
Q4 2025 86.00K $301.86K Hold
Q1 2026 86.00K $307.88K Hold
Q2 2026 86.00K $294.12K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCKT and 13F data

RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 19 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCKT

All RCKT fund holders →

FAQ

How long has Lion Point Capital, LP held RCKT?

Lion Point Capital, LP has disclosed RCKT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Lion Point Capital, LP's current position in RCKT?

As of Q2 2026, Lion Point Capital, LP holds 86.00K shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $294.12K, representing 1.41% of its reported portfolio and ranking #25.

Has Lion Point Capital, LP been buying or selling RCKT?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in RCKT. The position peaked in Q1 2026 at 86.00K shares.

Which other funds hold RCKT?

Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Newtyn Management, LLC, Maverick Capital, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.